Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
about
Travel Medicine for the Extreme TravelerPathophysiology and impact of enteric bacterial and protozoal infections: new approaches to therapy.Review article: travellers' diarrhoea.In vitro activity and fecal concentration of rifaximin after oral administrationIn vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regionsEmpirical antimicrobial therapy for traveler's diarrhea.Drug prophylaxis for travelers' diarrhea.Guidelines for adults on self-medication for the treatment of acute diarrhoea.Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.Therapy of travelers' diarrhea with rifaximin on various continents.Prevention and self-treatment of traveler's diarrhea.Rifaximin for the treatment of acute infectious diarrheaAntibiotics for the treatment of irritable bowel syndromeReview article: the antimicrobial effects of rifaximin on the gut microbiota.Rifaximin: a new treatment for travelers' diarrhea.Rifaximin in the treatment of infectious diarrhea.Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials?Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.Prevention and treatment of traveler's diarrhea. Focus on antimicrobial agents.Current and future developments in travelers' diarrhea therapy.Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseasesThe role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea.Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.Rifaximin: recent advances in gastroenterology and hepatologyOpen Clinical Trial on Using Nifuroxazide Compared to Probiotics in Treating Acute Diarrhoeas in Adults.The practice of travel medicine: guidelines by the Infectious Diseases Society of America.Rifamycin SV MMX for the treatment of traveler's diarrhea.In vitro activity of rifaximin against enteropathogens producing traveler's diarrheaRifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.
P2860
Q27480972-3F01DED2-8C43-46FD-93A4-AB91E16A3B0FQ30436681-7E034304-FF06-4501-8C05-3A8327E216BAQ33778796-B63542AF-B3A1-4554-92E0-384EBFF466B2Q33980321-43B56C9C-F1EF-483C-BE67-28FBEB151354Q33981185-76AA5FF3-E3FA-48C7-A43D-AFD2AF83F3B1Q34069481-559A4345-0210-4947-837F-73C3B92A6E86Q34110485-EE05A975-6E06-47BD-BE73-ADA2880A74A3Q34266228-46710966-BF14-40C5-9424-36479F6C885BQ34519193-B68D968A-644B-40F6-8C62-97CA42B1EA3AQ34534555-C3DB2CC9-A152-4EF1-A4F7-AC8E87D7D7A0Q34974972-69A5153E-17C8-4D09-8F35-2DFA68E33DD6Q35090413-2317B149-E61F-45B7-951C-59626B11C737Q35691133-11A4C943-D327-4013-B1BB-88DB353EB6A2Q35855732-F42B5CF5-1336-4E45-98E2-570E7C518FB9Q35983943-AA8228D5-D4A2-45C8-B3AA-85B70FC4AAB4Q36108487-02FF31FD-FB13-4DA5-BFC5-571088AFFD95Q36108490-35DA9886-B7A6-4555-BCE1-AD68806F4221Q36140657-40F28E7E-2BCE-48FD-BB59-B9558D3DAB74Q36404962-B47EB456-5FE4-490E-8602-A992A122C965Q36505498-59A188D3-217A-4834-B54C-2DB9DB8558B8Q36533648-08EDD4AD-591A-4706-B7F5-696AF9AB3855Q37412963-35955F43-CAEA-4A50-AD0F-6E38211BA760Q37678916-9C6F5431-0197-417F-8603-E34043194D95Q37768415-AFE6522F-33ED-4267-BC78-F0C25B12DE39Q38074951-CF3F03C3-A344-4BDA-BB30-14DE46A2E4ECQ38988039-2ACE2AB5-CE9E-46FE-BDB7-C168852958B3Q39067681-43DBDC69-1F7A-42C4-B54D-807196FE4118Q39428832-BEC8610E-3915-46C3-8133-B86D3EE74634Q42730284-D058A091-9D17-4553-A6C5-FB3E7C41416FQ42952867-CFDC7E3D-94A7-4607-8BA8-8D7CFF65FCD6
P2860
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@ast
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@en
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@nl
type
label
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@ast
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@en
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@nl
prefLabel
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@ast
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@en
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@nl
P2093
P356
P1433
P1476
Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea.
@en
P2093
C D Ericsson
E Palazzini
F J de la Cabada
H L DuPont
J J Mathewson
M W DuPont
P304
P356
10.1159/000007580
P577
1998-11-01T00:00:00Z